Organigram Holdings Inc. has rebranded to Organigram Global Inc., a move that illustrates the company’s aim to accelerate global expansion. 

With strategic international investments and expanding export partnerships, Organigram says it is focused on bringing Canadian-grown cannabis to the world.

“As Organigram has grown from its roots in Atlantic Canada to become a global player, our identity needed to evolve alongside our business,” said Beena Goldenberg, CEO of Organigram Global. “We’re not just a Canadian success story — we are a global cannabis innovator, exporting premium products, expanding into international markets, and shaping the future of the cannabis industry. Our new brand identity is a powerful reflection of who we are today.”

The rebranding includes a new logo, a refreshed visual identity and a new website showcasing Organigram’s strategic direction, product innovations and global partnerships.

The company’s international expansion plans include:

• Strategic investment in German cannabis leader Sanity Group, which holds roughly 7% market share, distributes to more than 2,000 pharmacies, and is participating in multiple recreational pilot projects with applications pending in six German jurisdictions, as well as existing stores in Switzerland.
• EU-GMP certification is expected to be completed in the upcoming months, giving Organigram the ability to scale exports further.
• Organigram has been actively finalizing a strategy that positions the company to participate in the U.S. market in a more meaningful way. In the meantime, Organigram already has two investments in the U.S., creating strategic advantages that expand reach and enhance offerings. Open Book Extracts provides access to hemp-derived extracts and formulations, and Phylos Bioscience drives innovation in cannabis technology including providing Organigram with exclusive access to proprietary genetics.
• Organigram continues to export indoor-grown cannabis to Australia, Germany and the United Kingdom and expects to increase shipments in the coming years.

Organigram continues to identify investment opportunities for Jupiter, the strategic investment pool made possible by BAT’s follow-on investment announced in November 2023.

“As Organigram Global continues to expand, the new brand identity signals a commitment to international excellence, innovation and industry leadership,” said Megan McCrae, senior vice president, global brands and corporate affairs. “The company remains dedicated to delivering high-quality, science-backed cannabis products, leveraging its strong foundation in Canada to fuel further global expansion. Organigram Global is more than a new name — it’s a statement of intent. We are growing. We are leading. And we are bringing the best of Canadian cannabis to the world.”

As announced on March 24, Organigram’s shareholders approved the name change. Subject to TSX approval, the company's common shares will begin trading on the TSX and NASDAQ under the new name on or about March 31. The trading symbol will remain unchanged as OGI. As part of the name change, Organigram’s common shares have been assigned new CUSIP 68617J100 and ISIN CA68617J1003 numbers, and the company’s warrants have been assigned new CUSIP 68617J118 and ISIN CA68617J1185 numbers.